CytomX Therapeutics, Inc.
$812.63M- Market cap
- $808.41M
- Debt
- +$16.89M
- Cash
- −$12.67M
Capital structure 98% equity / 2% debt · EV / Revenue 10.66x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
CTMX · current priceP/S 10.61x
$3.71Latest market snapshot
Implied fair value · at BBWI's multiple
$0.3092.0% below market
0.55 CTMX revenue / share×0.54x BBWI P/S=$0.30
Market $3.71Implied $0.30
BBWI · current priceP/S 0.54x
$19.51Latest market snapshot
Implied fair value · at CTMX's multiple
$383.591,866.1% above market
36.16 BBWI revenue / share×10.61x CTMX P/S=$383.59
Market $19.51Implied $383.59